Quattro Financial Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Quattro Financial Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-374	Closed	-$32.4K	–	86
2019 Q2	$32.4K	Buy	+374	New	+$31.9K	0.01%	77
2019 Q1	–	Sell	-374	Closed	-$30.9K	–	77
2018 Q4	$30.9K	Buy	374 +124	+50%	+$9.99K	0.01%	88
2018 Q3	$22.3K	Buy	+250	New	+$24.2K	0.01%	76

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Quattro Financial Advisors's XBI Position: Q3 2019 in Review

Quattro Financial Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2019, closing a stake of 374 shares — an estimated $32.4K sold.

Quattro Financial Advisors first reported a position in XBI in Q3 2018 and held it in 3 quarters. The position peaked at $32.4K in Q2 2019. 406 funds tracked by Wall St. Rank hold XBI as of Q3 2019.

Quattro Financial Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2019 after selling out during the quarter.
Quattro Financial Advisors sold 374 State Street SPDR S&P Biotech ETF shares in Q3 2019, an estimated $32.4K.
Quattro Financial Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q3 2018 and held it in 3 quarters.
Quattro Financial Advisors's State Street SPDR S&P Biotech ETF position peaked at $32.4K in Q2 2019.
406 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2019.

Based on Quattro Financial Advisors's 13F filing for Q3 2019, filed 10 Oct 2019.